Which has grown faster, BLFS or NTLA?

Over the past five years, NTLA grew revenue faster — BLFS at a 6.78% CAGR versus NTLA at 7.31%.

Is BLFS or NTLA more profitable?

BLFS runs the higher net margin — BLFS at 49.06% versus NTLA at -672.16%.

How have BLFS and NTLA total returns compared?

Over the past 10 years, BLFS delivered 36.27% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.

BioLife Solutions, Inc. (BLFS) vs Intellia Therapeutics, Inc. (NTLA)

A side-by-side comparison of BioLife Solutions, Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BLFS

BioLife Solutions, Inc.

$1.89B

$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

NTLA

Intellia Therapeutics, Inc.

$1.78B

$12.74HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — BLFS vs NTLA

growth of $100 · dividends reinvested · last 10y

BLFS +2119.0% (+36.3%/yr)NTLA -26.5% (-3.0%/yr)BLFS compounded faster over this window

Log scale — wide-divergence pair

BLFS NTLA

BLFS vs NTLA: by the numbers

•BLFS is the larger company ($1.89B vs $1.78B market cap).
•BLFS is profitable (49.06% net margin) while NTLA runs a net loss (-672.16%).
•NTLA grew revenue faster over the past five years (7.31% vs 6.78% CAGR).

Metrics side by side

Valuation

Metric	BLFS	NTLA
P/E ratio	37.72	N/A
Forward P/E	64.35	N/A
P/S ratio	18.35	29.91
P/B ratio	4.49	2.45
EV / EBITDA	170.26	N/A

Profitability

Metric	BLFS	NTLA
Gross margin	64.48%	76.47%
Operating margin	-1.12%	-651.67%
Net margin	49.06%	-672.16%
ROE	12.01%	-54.96%
ROIC	1.72%	-54.45%

Growth (annualized)

Metric	BLFS	NTLA
Revenue CAGR (5Y)	6.78%	7.31%
Total return CAGR (5Y)	-0.77%	-37.13%

Frequently asked

Which has grown faster, BLFS or NTLA?: Over the past five years, NTLA grew revenue faster — BLFS at a 6.78% CAGR versus NTLA at 7.31%.
Is BLFS or NTLA more profitable?: BLFS runs the higher net margin — BLFS at 49.06% versus NTLA at -672.16%.
How have BLFS and NTLA total returns compared?: Over the past 10 years, BLFS delivered 36.27% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BLFS analysis Full NTLA analysis Interactive comparison tool

Dig into the metrics

BioLife Solutions P/E ratio BioLife Solutions ROE Intellia Therapeutics ROE BioLife Solutions operating margin Intellia Therapeutics operating margin BioLife Solutions revenue growth Intellia Therapeutics revenue growth BioLife Solutions free cash flow Intellia Therapeutics free cash flow

BioLife Solutions & Intellia Therapeutics appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.